Showing results (171-180 of 329) with videos related to
Sort By:
Pageof 33
Synapse (New York, N.Y.)|November 16, 2004
Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002Robin J Tyacke, Emma S J Robinson, Maggie D M Lalies, et al.The American Journal of Psychiatry|May 7, 2025
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for DepressionMatthew B Wall, Lysia Demetriou, Bruna Giribaldi, et al.Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed ratsDavid P Finn, Alan L Hudson, Hiroshi Kinoshita, et al.Psychopharmacology|November 27, 2007
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokersBrian Hitsman, James MacKillop, Anne Lingford-Hughes, et al.Journal of Psychopharmacology (Oxford, England)|April 17, 2010
The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerabilityRobin L Carhart-Harris, Tim M Williams, Ben Sessa, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 2025
Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjectsNatalie Ertl, Imran Ashraf, Lisa Azizi, et al.Psychiatry Research|October 7, 2003
Correlation of subjective and objective sleep measurements at different stages of the treatment of depressionSpilios V Argyropoulos, Jane A Hicks, Jon R Nash, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|June 10, 2025
MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-upHannah Thurgur, Ben Sessa, Laurie Higbed, et al.Neuroimage|May 11, 2010
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challengePaul R A Stokes, Alice Egerton, Ben Watson, et al.Psychiatry and Clinical Neurosciences|February 26, 2026
Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsKengo Yonezawa, Mayuko Hirata, Hiroaki Takano, et al.Pageof 33